Search NLS News

Getinge has announced an agreement to acquire 100% of the shares in High Purity New England, a US-based company in the areas of custom single-use solutions for bioprocessing applications. “This acquisition is another step in Getinge Life Science strategic journey to further expand our presence in the biopharma segment,” says Eric Honroth, President Life Science […]

The capital injection will be used to further develop the company’s unique process that enables discovery and manufacture of next generation cell therapies for cancer on an industrial scale. The financing also allows Anocca to progress the company’s first products into clinical trials, it states. “In recent years, we have made great progress in automating […]

A vaccine against Lyme disease is now being tested in Sweden. “A new vaccine will probably be on the market within a couple of years,” says Johan Sanmartin Berglund, Professor of applied health technology at Blekinge Institute of Technology. About the study Over 15,000 people are included in the study which is led by Blekinge […]

AnaMar has announced results from its Phase I study, and the completion of Phase II enabling pre-clinical studies for its initial orphan indication in systemic sclerosis (SSc) characterized by lung and skin fibrosis. AM1476, a highly selective small molecule, delivered as an orally administered tablet, was found to be safe and well-tolerated at all relevant […]

The Iceland-founded biopharmaceutical company was officially listed on the Nasdaq stock exchange in New York, making it the first Icelandic VC portfolio company to go public. Both Klappir and Solid Clouds were previously listed on the Nasdaq First North Growth Market in Iceland, but neither counted Icelandic VC’s as investors when going public. The same […]

Novo Nordisk has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending once-weekly Sogroya (somapacitan) for replacement of endogenous growth hormone (GH) in children aged three years and above, and adolescents with growth failure due to growth hormone deficiency. “Today’s positive CHMP opinion […]

The focus on real world evidence (RWE) and its potential to support regulatory decision-making has gained global traction. Regulatory bodies, such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), have released their expectations for the use of real world data (RWD) and RWE. In July 2022, the International Coalition […]

The U.S. Food and Drug Administration has granted Orphan Drug Designation (ODD) to the company’s lead asset mitazalimab for the treatment of pancreatic cancer. “This designation is a key milestone for our lead asset mitazalimab, which is producing outstanding clinical results in its Phase 2 trial in pancreatic cancer,” says Søren Bregenholt, CEO of Alligator […]

Researchers at Karolinska Institutet have developed a molecular method able to detect whether or not bacteria respond to antibiotics within minutes. The findings are presented in the journal Nature Microbiology and the researchers now hope to develop a simple test for doctors to use. “We are confident and hope that this can be one of […]

On behalf of the Swedish government, the Swedish innovation agency Vinnova has decided on funding of an innovation cluster for commercialization, competence development and production capacity for advanced therapies. The new cluster will serve as a national infrastructure and competence node for the benefit of companies throughout the country and it will also strengthen Sweden’s […]